Morsua, Jaime M.

HRN: 14-74-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/09/2024
01/15/2024
IV
1.5g
Q8
CAP-MR; Pleural Effusion
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: